|Home | About | Journals | Submit | Contact Us | Français|
MicroRNAs (miRNAs) are small non-coding RNAs that can exert multilevel inhibition/repression at a post-transcriptional or protein synthesis level during disease or development. Characterisation of miRNAs in adult mammalian brains by deep sequencing has been reported previously. However, to date, no small RNA profiling of the developing brain has been undertaken using this method. We have performed deep sequencing and small RNA analysis of a developing (E15.5) mouse brain.
We identified the expression of 294 known miRNAs in the E15.5 developing mouse brain, which were mostly represented by let-7 family and other brain-specific miRNAs such as miR-9 and miR-124. We also discovered 4 putative 22-23 nt miRNAs: mm_br_e15_1181, mm_br_e15_279920, mm_br_e15_96719 and mm_br_e15_294354 each with a 70-76 nt predicted pre-miRNA. We validated the 4 putative miRNAs and further characterised one of them, mm_br_e15_1181, throughout embryogenesis. Mm_br_e15_1181 biogenesis was Dicer1-dependent and was expressed in E3.5 blastocysts and E7 whole embryos. Embryo-wide expression patterns were observed at E9.5 and E11.5 followed by a near complete loss of expression by E13.5, with expression restricted to a specialised layer of cells within the developing and early postnatal brain. Mm_br_e15_1181 was upregulated during neurodifferentiation of P19 teratocarcinoma cells. This novel miRNA has been identified as miR-3099.
We have generated and analysed the first deep sequencing dataset of small RNA sequences of the developing mouse brain. The analysis revealed a novel miRNA, miR-3099, with potential regulatory effects on early embryogenesis, and involvement in neuronal cell differentiation/function in the brain during late embryonic and early neonatal development.
A class of small non-coding RNA (19-25 nt in length) known as microRNA (miRNA) [1-3] can exert multilevel inhibition/repression processes during post-transcriptional or protein synthesis stages [4,5]. miRNAs are transcribed in the nucleus into long polyadenylated RNAs known as primary (pri)-miRNAs that contain ~60-90 nt secondary hairpin structures termed precursor (pre)-miRNAs. The RNase III enzymes Rnasen and Dgcr8 then excise the pre-miRNA from the pri-miRNA [1,6-9]. The pre-miRNA hairpin is transported into the cytoplasm via the nuclear transport receptor, Xpo5, and further processed by another RNase III enzyme, Dicer, into a small RNA duplex containing the functional mature miRNA and a passenger strand known as miRNA star [9-11]. The majority of the miRNA star are non-functional and are rapidly degraded, but a small proportion have conserved seed regions, potentially with regulatory roles . The mature miRNA forms a component of the RNA-induced silencing complexes (miRISC) and guides these complexes to mRNA targets via sequence-specific pairing between the miRNA seed sequence (the first 7 nt of the miRNA starting from position 2) and the mRNA. Typically, miRNAs guide the RISC complex to the target mRNA 3' UTR, but incidences where 5' UTR and coding-sequences were targeted have been reported [13-15]. In mammals, miRISC normally effects translational repression and, depending on the degree of miRNA:mRNA sequence complementation, can direct mRNA degradation [5,16]. Another intriguing regulatory role of miRNAs is the silencing of gene transcription which has been observed in plants , but has not yet been reported in the mammalian system.
Mammalian brain development requires meticulous spatio-temporal regulation of gene/protein expression, from the transcription of DNA within the nucleus to translation of mRNA in the cytoplasm [18,19]. At embryonic day 15.5 (E15.5), the mouse brain undergoes rapid cellular and anatomical changes involving neuronal migration in the cerebral cortex, proliferation of neural progenitor/stem cells at germinative zones, gliogenesis, axonogenesis and rostro-lateral to caudo-medial structure patterning [20-22]. MiRNAs play crucial roles during brain development and function. MiR-134, for example, is localised to the synapto-dendritic compartment of rat hippocampal neurones and has been linked to synaptic development, maturation and plasticity . MiR-9 regulates the patterning activities and neurogenesis at the midbrain-hindbrain boundary in zebrafish  and miR-124 triggers brain-specific alternative pre-mRNA splicing leading to neuronal differentiation in the mouse . MiRNAs are also associated with neurological disorders such as schizophrenia  and Huntington's disease . To date, there are only 672 mature miRNAs in the mouse genome and 1048 in the human genome (miRBase release 16.0, September 2010)  in the mouse and human genomes, respectively. These figures are likely to be a gross underestimate of the actual number of miRNAs expressed. Most miRNAs are short lived, expressed in low abundance and found in specialised cell types during a specific developmental stage, and are therefore likely to remain uncharacterised due to technical limitations or the biological complexity of the tissues and cells of interest.
The emergence of next-generation sequencing technologies based on the massively parallel sequencing (MPS) concept has revolutionised the field of genomics and transcriptomics [29,30]. High-throughput generation of sequences from DNA or RNA has enabled the discovery of rare transcripts, such as alternatively spliced or fusion transcripts, as well as transcripts with low abundance [31,32]. Many next-generation sequencing datasets for small RNAs have been generated from the adult rodent and human brains [33-38]. However, to date, no small RNA profiling of the developing rodent or human brain has been performed using these methods. In this study, we performed deep sequencing of small RNAs prepared from an E15.5 mouse brain. In silico and laboratory based analyses led us to the discovery of 4 putative miRNAs; mm_br_e15_1181, mm_br_e15_279920, mm_br_e15_96719 and mm_br_e15_294354. Of these, mm_br_e15_1181 is novel and potentially involved in mouse embryogenesis, and brain development and function. This novel miRNA has been identified as miR-3099.
A total of 3,763,491 36 nt sequence reads were generated from a cDNA library constructed from mouse E15.5 whole brain small RNAs. The dataset was deposited into NCBI Gene Expression Omnibus GSE22653. Clustering of these sequence reads revealed 413,494 unique tags (Additional file 1). Screening for adaptor sequences (both 5' and 3') using a local blastn program showed 105,993 unique tags (6.9% or 259,681 sequence reads) did not have adaptor sequences indicating contamination of larger RNA transcripts during library construction (Figure (Figure1A).1A). Cloning errors resulted in 40,622 unique tags (11.0% or 413,837 sequence reads) consisting of only 5'and 3' adaptor sequences. The remaining 266,879 unique tags (82.1% or 3,089,973 sequence reads) were considered legitimate as they contained partial adaptor sequences at 5' or 3' or both ends.
Of the legitimate unique tags, 59,710 (6.5% or 245,722 sequence reads) belonged to the 26-29 nt category, whereas 131,383 unique tags (61.5% or 2,314,244 sequence reads) of 20-25 nt were discovered, and therefore formed the majority of the small RNAs found in the cDNA library (Figure (Figure1B).1B). A total of 48,902 unique tags (3.8% or 141,783 sequence reads) were classified into the 16-19 nt category and 26,884 unique tags (10.3% or 388,224 sequence reads) of 16 nt or shorter were generated from either a pool of very small RNAs with unknown function or random RNA degradation by-products. The recent identification of tiny RNAs (~17-18 nt) shows that these small RNAs are associated with transcription initiation and splice sites specific to metazoans [40,41] suggesting that these tiny RNAs could be functional and represent another level of regulation during gene transcription in the nucleus.
Bowtie analyses, allowing only perfect matches, were performed on both the 5' and 3' end of each of the unique tags resulting in 339,201 tags (42% or 1,579,209 sequence reads) not finding a match in the mouse genome. This large proportion of unmatched unique tags included adaptors and low quality tags with errors in sequencing/base-calling. In exceptional circumstances, these unique tags could be derived from intron/exon or exon/exon boundaries, fusion transcripts or uncharacterised genomic regions. These unique tags with their corresponding sequence reads were not included for further analysis. The number of unmatched sequences varies from one study to another. Morin and colleagues reported 29-35% of their total sequence reads generated from human embryonic stem cells and embryoid bodies small RNA libraries either consisted of errors or were not perfectly matched to the human genome . In a different study, deep sequencing of small RNA libraries generated from cold-treated and untreated Brachypodium monocot plants resulted in only 49-54% of total sequence reads matching perfectly to the genome . These studies suggested that a large proportion of the total sequence reads produced by deep sequencing are discarded from further analysis due to the quality of the sequence reads and stringency imposed during sequence alignment.
A total of 74,293 unique tags (58% or 2,184,282 sequence reads) were perfectly matched to the mouse genome. Of these, 7,136 (6.2% or 234,381 sequence reads) were matched to repetitive elements, and 6,929 (0.5% or 17,853 sequence reads) were matched to 'infrastructure' non-coding RNAs such as tRNA, rRNA, scRNA, snRNA or snoRNA (Table (Table1;1; Additional files 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12). These unique tags and their corresponding sequence reads were also excluded from further analysis. A total of 45,623 unique tags (49.6% or 1,867,113 sequence reads) were matched to either mature miRNA, miRNA star or pre-miRNA from miRBase, 2,448 (0.1% or 2,775 sequence reads) were matched to RefSeq, 6,584 (1.3% or 48,465 sequence reads) were matched to redundant mouse EST sequences, 1,752 (0.2% or 7,656 sequence reads) mapped to a single genomic locus and 3,821 (0.2% or 6,039 sequence reads) mapped to multiple loci within the genome (Figure (Figure1C).1C). Intriguingly, a large number of mapped unique tags in unique genomic loci have low abundance and lack association with any known mouse mRNAs, ESTs or miRNAs suggesting that these small RNAs could be generated from specific type of cells at specific stages of development and therefore have not been characterised to date.
To assess the expression of known miRNAs in the developing mouse brain at E15.5, we analysed all 294 mapped miRNAs in the dataset. Their counts ranged from 1 to 487,654 sequence reads or 0.27 to 129,575 per 1,000,000 sequence reads (CPM). The top 10% of the most abundantly expressed miRNAs are presented in Table Table22 (see full list of known miRNAs in Additional file 13). The most abundantly expressed miRNA in the E15.5 developing mouse brain is let-7c-1 with its 7 family members (let-7a-2, let-7b, let-7d, let-7e, let-7f-2, let-7g and let-7i) having a combined 335,288 CPM. Our finding agrees with the first report by Lagos-Quintana and colleagues  regarding the high representation of let-7 family members in the mouse brain, which was also later found in the primate brain . Despite their high level of expression in the brain, the functional role of let-7 in the development of the central nervous system is poorly characterised. However, the expression of let-7 has been associated with neural differentiation and lineage specification processes in early brain development .
Other miRNAs or miRNA families that were abundantly expressed in the E15.5 developing mouse brain include miR-124 (3,958 CPM), which promotes and regulates neuronal differentiation  and miR-9 (47,981 CPM), which has a role in the patterning activities and neurogenesis of the central nervous system . MiR-128 (7,303 CPM) was highly expressed in our dataset and the finding is in agreement with a previous study . Down-regulation of miR-128 expression has been associated with glioblastoma multiforme  whereas its up-regulation has been implicated with reduced neuroblastoma cell motility, invasiveness and cell growth . In addition, both miR-128 and miR-9 are highly expressed in the foetal hippocampus and differentially regulated in the normal adult hippocampus as well as the hippocampus of Alzheimer's disease sufferers . MiR-125 (5,811 CPM) and miR-99 (12,280 CPM) were also expressed highly in the developing mouse brain. Together with let-7c, both miR-125 and miR-99 are over-expressed by at least 50% in the foetal hippocampus of individuals with Down syndrome compared to age and sex matched controls suggesting that miRNAs are playing an important role in this brain region, which is pertinent for learning and long-term memory formation . Interestingly, the miR-103-2 (16,537 CPM), miR-107 (2,068 CPM), miR-181 (6,627 CPM) and miR-30 (5,740 CPM) families have not previously been associated with the development of the brain, but were found to be highly expressed in our dataset. Both miR-103 and miR-107 are paralogous miRNAs and have been associated with lipid metabolism . MiR-181 plays a crucial role in modulating haematopoietic lineage differentiation  whereas miR-30 has been strongly implicated with kidney development and nephropathies .
The identification of brain-related miRNAs by our deep sequencing analysis shows that the dataset is reliable not only for characterising expression profiles of known miRNAs but also for discovery of novel miRNAs. Further investigation of these miRNAs may shed light on their regulatory roles in various molecular pathways underlying the development of the embryonic brain.
To identify putative miRNAs, we analysed unique tags with a single match to the genome that were annotated as matched to RefSeq or redundant mouse EST sequences or were without annotation. A total of 10,784 unique tags (1.6% or 58,896 sequence reads) were selected under these criteria. We included all sequences with 1-2 counts into the analysis because we had found 34 known miRNAs residing in a similar range of expression within the dataset (see Additional File 13), suggesting some of the single count unique tags might be true positives. Pre-miRNA sequences were predicted using the RNA22 program, a pattern-based method reported previously . The program predicted 8 putative miRNAs with pre-miRNA sequences; mm_br_e15_1181, mm_br_e15_279920, mm_br_e15_96719, mm_br_e15_294354, mm_br_e15_276138, mm_br_e15_331608, mm_br_e15_255873 and mm_br_e15_363469 (see Additional File 14). The resulting candidate pre-miRNA sequences were subjected to hairpin structure or fold prediction using the RNAfold program . Of all the candidate putative miRNAs, only 4 fulfilled the criteria outlined for mature miRNA and pre-miRNA . These were mm_br_e15_1181 (chr7:6756349-6756370), mm_br_e15_279920 (chr2:29597247-2959768), mm_br_e15_96719 (chr7:68982209-68982231), and mm_br_e15_294354 (chr7:68935407-68935429) which featured a 22-23nt mature miRNAs and a 70-76nt predicted pre-miRNAs (Figure 2A B and and2D).2D). The other 4 putative miRNAs, mm_br_e15_276138, mm_br_e15_331608, mm_br_e15_255873 and mm_br_e15_363469 contained a large internal loop, branching stem or oversized pre-miRNA structural properties (see Additional file 14). These putative miRNAs were excluded from further analysis.
Mm_br_e15_1181 was matched to the second intron of the ubiquitin specific peptidase 29 (Usp29) gene. Mm_br_e15_279920 was matched to a single locus within the mouse genome without any annotations, whereas both mm_br_e15_96719 and mm_br_e15_294354 miRNAs were matched to two different introns of the same EST, BU505171. We performed a small RNA northern analysis on the E15.5 whole brain small RNAs to validate all the 4 predictions. We also included mm_br_e15_276138, mm_br_e15_331608, mm_br_e15_255873 and mm_br_e15_363469 in our northern analysis to serve as negative controls. The analysis confirmed all 4 predictions at the mature miRNA level for mm_br_e15_1181, mm_br_e15_96719 and mm_br_e15_294354, and at the pre-miRNA level for mm_br_e15_1181 and mm_br_e15_279920 (Figure (Figure2C).2C). As expected, the northern analysis of negative controls showed no detectable signals for mm_br_e15_276138 and mm_br_e15_363469, and multiple bandings for mm_br_e15_331608 and mm_br_e15_255873, signifying random by-products due to RNA degradation (see Additional file 14). Depending on the biological context of the assessed tissue, miRNA may be preserved or accumulated at the pre-miRNA level due to specific factors such as the activity levels of dicer, argonaute or nuclear export receptors [57-59]. Therefore, we considered the existence of these small RNAs validated when either the mature or precursor miRNA with specific size was detected using the northern analysis.
Further analysis using the University of California, Santa Cruz (UCSC) genome browser  showed that mm_br_e15_1181 was mapped to a region within the mouse genome that is homologous to the rat and horse genomes. Other putative miRNAs were mapped either to a region specific to the mouse genome (mm_br_e15_294354) or a region homologous to the rat only (mm_br_e15_279920 and mm_br_e15_96719) (Figure (Figure2D).2D). By using both the full-length and seed sequences of all the 4 putative miRNAs, we performed homology searches against all the known miRNA sequences and were unable to find any orthologous miRNAs, indicating that these putative miRNAs could be specific to the mouse or rat especially mm_br_e15_1181 and mm_br_e15_96719. Sequence conservation of miRNAs is relatively common among vertebrates as well as invertebrates. For example miR-263 (consisting of miR-263a and miR-263b) and miR-183 (consisting of miR-96, miR-182 and miR-183) families are found in many organisms including human, mouse, chicken, zebrafish, frog, worm and fruit fly, with high sequence and expression profile similarity particularly in sensory organs [61,62]. However, lack of sequence homology among miRNAs from different organisms does not negate the possibility of functional conservation among them. For example, both lin-4 and let-7 target multiple sequence motifs at the 3' UTR of Caenorhabditis elegans hunchback homolog mRNA, hbl-1, and regulate its expression in the ventral nerve cord neurones . In addition, different miRNAs with similarity at the seed region may exert the same effect on a same mRNA. Drosophila bearded (Brd) gene has motifs that are complementary to two different miRNAs, miR-4 and miR-79, which bear the same seed sequence. Both the miRNAs target the motifs based entirely on the seed sequence with little or no base-pairing to the 3' region . Although this phenomenon is rare across different organisms, it proves that functional conservation between non-conserved miRNAs may lie within the seed region alone.
Of the 4 putative miRNAs, we selected mm_br_e15_1181 for further characterisation due to its high copy number. First, we evaluated mm_br_e15_1181 expression in mouse embryonic stem (mES) cells, with and without Dicer1 enzyme activity using the stemloop RT-qPCR technique (Figure (Figure3A).3A). Mm_br_e15_1181 was expressed in mES cells with Dicer1 activity, however its expression was not detected or was weak in cells lacking Dicer1 activity confirming that mm_br_e15_1181 biogenesis is Dicer1-dependent (P < 0.01). The evaluation of Dicer1-dependency using the mES cell model is limited to miRNAs that are expressed in this cell type. It is worth noting that Dicer1-dependency is not a definitive property for defining mm_br_e15_1181 as a novel miRNA because endogenous small siRNAs are also subjected to the same dicing mechanism in the cytoplasm . A recent study reported the Dicer1-independent biogenesis of miR-451, in which the catalytic activity of Argonaute2 was responsible for the pre-mir-451 hairpin cleavage process .
In this study, we used a number of validation analyses for mm_br_e15_1181: Dicer1-dependence, pre-miRNA structure prediction and northern analysis to define mm_br_e15_1181 as a novel miRNA. This novel miRNA has been identified as miR-3099.
The expression of miR-3099 in mES cells led us to hypothesize that this miRNA may play a role in early embryogenesis and therefore we characterised its expression profile throughout development. Using stemloop RT-qPCR, we showed that miR-3099 was expressed in E3.5 blastocysts (Figure (Figure3B).3B). The expression of miR-3099 reduced (by ~9-fold; P < 0.001) as the blastocysts developed into an early stage embryo at day 7 (E7), suggesting that miR-3099 was either expressed in a spatially restricted manner or generally down-regulated at this stage. To specifically locate the expression of miR-3099 during embryogenesis, we performed whole mount in situ hybridisation on E9.5 embryos (n = 3) and showed that miR-3099 was expressed throughout the embryo with the exception of the developing heart (Figure (Figure3C).3C). Stronger expression was observed in the telencephalon, somites, branchial arches, and both forelimb and hindlimb buds. Cross sectional analysis of the telencephalon confirmed that miR-3099 was expressed in the neuroepithelium (Figure (Figure3D).3D). Whole mount ISH analysis on embryos of the same age was performed using miR-scrambled LNA probe to serve as the background control (n = 2) (Figure (Figure3E3E &3F).
To evaluate the expression profile of miR-3099 in the later stages of embryogenesis, we performed section ISH. Section ISH of the E11.5 whole embryos showed that miR-3099 was expressed throughout the embryo, especially in the preplate of the telencephalon, somites and hindlimb region (Figure (Figure4).4). By E13.5, miR-3099 expression was restricted to the cortical plate of the cortical neuroepithelium, striatum, medial pallium (hippocampal allocortex) and subventricular/ventricular zone of the superior and inferior colliculi. In E15.5 embryos, miR-3099 expression was observed primarily in the cortical plate of the cerebral cortex. In E17.5 whole brains, miR-3099 expression was prominent in the cortical plate, piriform cortex and at lower levels, in the hippocampal formation. Embryo-wide expression of miR-3099 during early embryogenesis suggests a pan-regulatory role, possibly functioning as a 'housekeeping' miRNA in basic cellular processes. This feature has been described in a few clusters of miRNAs expressed in the mouse retina, brain and heart . Many miRNAs have ubiquitous expression patterns and their function remains unclear as they may have roles in subtle miRNA networks, which exert combinatorial effects during development [67,68]. Contrasting with the almost ubiquitous expression profile in early development, miR-3099 was not detected in a few regions such as the E9.5 developing heart and the ventricular zone of the telencephalon/developing cerebrum. This suggests that the function of miR-3099 may be tissue or cell-specific, especially after E11.5, this warrants further characterisation.
We also performed stemloop RT-qPCR expression analysis of miR-3099 in various regions of the mouse brain and organs. Using the mouse whole brain, there was a significant difference (P = 0.02) in the miR-3099 expression among E11.5, E13.5, E15.5, E17.5, postnatal day (P) 1.5 and P150 samples (Figure (Figure5A).5A). MiR-3099 expression was found to be increased after E11.5 and was maintained in postnatal day 1.5 (P1.5) and P150 whole brains. The qPCR analysis supports the previous section ISH analysis. No significant differences (P = 0.45) in miR-3099 expression were observed among cerebellum, cerebrum, hippocampus, medulla, olfactory bulb and thalamus (Figure (Figure5B).5B). When we compared the expression of miR-3099 in various adult mouse organs to the P150 whole brain, we found significant differences in the expression levels among the organs (P < 0.001) (Figure (Figure5C).5C). MiR-3099 was found to be expressed at the highest level in the pancreas, followed by the thymus, large intestine, heart, small intestine, kidney, brain, testis, ovary, skin, skeletal muscle, liver, stomach and spleen. Similar to the embryonic expression profiles, the diverse expression profile of miR-3099 in multiple organs of the adult mouse further supports a widespread role in the development and function of these organs.
Expression of miR-3099 was observed in the preplate of the E11.5 telencephalon and later in the cortical plate of the E13.5-E17.5 cerebral cortex, by which time the majority of the cells in these structures are committed to their respective neuronal lineages. This finding further suggests that miR-3099 may play an important regulatory role during neurogenesis or in neuronal function. To further test this idea, we used P19 teratocarcinoma cells as an in vitro model. Upon retinoic acid induction and under reduced serum concentration, P19 cells differentiate into glutamatergic and glutamate-responsive neurones, glial and fibroblast-like cells [69-72]. We analysed the expression level of miR-3099 in P19 cells (Figure (Figure6A)6A) and found a statistically significant (P = 0.04) ~2-fold upregulation of miR-3099 in ~50% differentiated P19 cells compared to the proliferating cells (Figure (Figure6B).6B). Various miRNAs have been found to be upregulated during neural differentiation and some of their expression could be negatively regulated by important transcription factors such as Oct4 and Sox2, the expression levels of which gradually diminish as cells differentiate into neurones . Therefore, increased miR-3099 expression during P19 differentiation raises the possibility that this miRNA may have a functional role during neural differentiation or neuronal cell function.
In this study, we have reported the first deep sequencing analysis of small RNAs of a developing mouse brain. We have identified and validated 4 putative miRNAs from the analysis and further characterised one of them, miR-3099, during embryogenesis. A significant finding of the study was the embryo-wide expression profile of miR-3099 in mid-gestation embryos, which became restricted to the central nervous system, suggesting a role for this miRNA in neural differentiation or function.
The Melbourne Health Animal Ethics Committee and the University of Adelaide Animal Ethics Committee approved procedures involved in the breeding and handling of animals. Mice were housed under a 12-hour light and 12-hour dark cycle with access to unlimited food and water. Mice were culled by CO2 inhalation and all dissections of mouse embryos, brains and organs were carried out according to the methods described previously .
Total RNA was isolated from a whole brain dissected from an E15.5 embryo of C57BL/6 background using TRIzol reagent (Invitrogen) according to the manufacturer's protocol. Small RNAs with sizes ranging from 16-30nt were isolated from 10 μg total RNA using polyacrylamide gel electrophoresis. The complementary small RNA library was constructed using the Small RNA Sample Prep Kit version 1.0 (Illumina) according to the manufacturer's protocol with 5'-GTTCAGAGTT CTACAGTCCG ACGATC-3' and 5'-TCGTATGCCG TCTTCTGCTT GT-3' adapters at the 5' and 3' ends, respectively. Sequencing was carried out using a Genome Analyzer II (Illumina). Image data was generated by the Genome Analyzer II and was processed using the Illumina pipeline software (Pipeline version 1.0 was used for the FASTQ data). This consists of an image analysis module (Firecrest), followed by basecalling using the BUSTARD module and finally production of a data file in FASTQ format using the GERALD module.
The FASTQ data was ranked according to decreasing abundance of the unique tags. This file was created using a PERL script in Linux without taking into consideration any filters (adapter sequences) or quality. A file with unique tags and their corresponding counts was generated. All unique tags (including those with a single count) were mapped to the NCBI Mouse Assembly Build 37.1 using the Bowtie program . Two sets of alignments were carried out: one stripping off 14 bases from the 5' end of unique tags and the other stripping off 14 bases from the 3' end. In both alignments, no mismatches are allowed and unique tags that hit more than one locus within the mouse genome were discarded. Unique tags with a single hit within the genome were further annotated using various databases such as RepeatMasker (analysis was performed on NCBI Mouse Assembly build 37.1 and the output was downloaded from UCSC genome browser on the 28th of November, 2008), mouse RefSeq in release 32, mouse miRNA in miRBase release 12.0 and redundant mouse EST database (downloaded from UCSC mm9 on 27th January, 2009).
Unique tags that mapped to a genomic locus with a RefSeq, redundant EST or no annotations were subjected to pre-miRNA prediction using the RNA22 program . Sequences encompassing 100- to 200-nt upstream and downstream of these unique sequences were used to predict any potential pre-miRNAs with hairpin structures. The minimum number of patterns that should support a pre-miRNA before it can get reported was set to 60, and the minimum and maximum pre-miRNA lengths were set to 60nt and 150nt, respectively. All predicted pre-miRNA sequences based on these settings were used to determine the hairpin fold structure using RNAfold program . The predicted hairpin fold structure with the lowest minimum free energy (MFE) (cut off at -30 kcal/mol or lower) and conforming to the annotation criteria for pre-miRNA  was selected as the final predicted pre-miRNA. Briefly, the predicted precursor structure must be between 60-80 nt in size and must not have a large internal loop or any asymmetric bulges. The predicted pre-miRNA must contain the aligned unique sequence within one arm of the hairpin and include at least 16 bp from the 5' end of the unique sequence and the other arm of the hairpin.
Eight blots were prepared from four independent E15.5 whole brains. Approximately 30 μg of total RNA was denatured in 1X Ambion Gel Loading Buffer II (Ambion®) at 85°C for 3 minutes. RNAs were electrophoresed in 15% acrylamide/urea gels (48% (w/v) urea, 15% (v/v) acrylamide, 0.05% (w/v) ammonium persulfate and 0.1% (v/v) tetramethylethylenediamine prepared in 1X TBE) in 1X TBE buffer at 300 V for 90 minutes. Separated small RNAs in the gel were then transferred onto Hybond-N+ nylon membrane (GE Healthcare) using Trans-Blot® SD Semi-Dry Electrophoretic Transfer Cell (Bio-Rad) at a constant 0.4 V for 45 minutes. The pre-hybridisation step was carried out in Amersham Rapid-hyb™ Buffer (GE Healthcare) with 100 μg/ml of herring sperm DNA (Promega) at 42°C for 1 hour and was followed by the hybridisation step. The same pre-hybridisation solution was used for hybridisation with addition of 2 × 106 dpm/ml labelled probe prepared using 20 U of T4 Polynucleotide Kinase (Promega) in 1X kinase buffer (Promega) and 50 pmol of [γ-32P]-dATP (GE Healthcare) (3000 Ci/mmol). Hybridisation was carried out for 18 hours and filters were washed in 5 × SSC with 0.1% (w/v) sodium dodecyl sulfate (SDS) (20 minutes at 37°C) followed by 1 × SSC with 0.1% (w/v) SDS and 0.2 × SSC with 0.1% (w/v) SDS (15 minutes each time at 65°C until a clean background signal was obtained). The membrane was exposed to a storage phosphor screen in a cassette at room temperature for 1 day for miR-3099 blot and 8 days for other blots before scanned using Typhoon™ 9400 (GE Healthcare).
Reverse transcription of the small RNA was performed based on modified methods [75,76]. cDNA was synthesised from 150 ng-2.5 μg of small RNA enriched total RNA using 0.05 μM of an in-house designed stem loop primer (5'-GTTGGCTCT GGTAGGATG CCGCTCTCA GGGCATCCT ACCAGAGCCA AACTCCCCA-3', GeneWorks), and the Superscript® III Reverse Transcriptase Kit (Invitrogen) with modifications to the manufacturer's protocol. The stem loop primer was added after a denaturation step at 65°C for 5 minutes. The last 6nt at the 3' end of the stem loop primer complements the last 6nt of the 3' end of miR-3099 small RNA. The stem loop RT primer contains a target site for a universal reverse primer (5'-GTAGGATGCC GCTCTCAGG-3', GeneWorks) and a target site for UniversalProbe Library (UPL) Probe #21 (Roche Diagnostics), which were used in subsequent cDNA amplification processes together with a specific forward primer for miR-3099 (5'-CGCGTAGGCT AGAGAGAGGT-3', GeneWorks). Briefly, cDNA synthesis was performed at 16°C for 30 minutes followed by 60 cycles of 20°C for 30 seconds, 42°C for 30 seconds and 50°C for 1 second. A final incubation at 75°C for 15 minutes was performed to inactivate the reverse transcriptase enzyme.
Prior to qPCR, pre-PCR of miR-3099 was performed in a 10 μl reaction volume containing 1X LC480 Probe Master mix (Roche Diagnostics), 50 nM of each forward and universal reverse primers and 0.2X of synthesised cDNA. Pre-PCR was initially carried out at 95°C for 10 minutes, 55°C for 2 minutes and 75°C for 2 minutes and followed by 14 additional cycles of 95°C for 15 seconds and 60°C for 4 minutes. After pre-PCR, 0.01X of amplicons were used for qPCR.
QPCR was carried out in 10 μl reaction volume using 1X LightCycler 480 (LC480) Probe Master mix (Roche Diagnostics), 0.1 μM of a relevant Universal ProbeLibrary probe (Roche Diagnostics), 0.25 μM of each forward and reverse primers and 1 μl of 0.1X of synthesised cDNA. Reactions were prepared in 384-well plates and RT-qPCR was performed using a LightCycler® 480 Real Time PCR System instrument (Roche Diagnostics). QPCR was performed with an initial denaturation at 95°C for 10 minutes followed by 45 cycles at 95°C for 10 seconds, 60°C for 30 seconds and 72°C for 10 seconds, and a final step at 40°C for 1 second.
Real-Time amplification signals were acquired during the elongation step and recorded live using LightCycler® 480 Software version 1.5 (Roche Diagnostics). The cycle threshold or crossing point (Cp) from each signal was calculated based on the Second Derivative Maximum method . A 4-data point standard curve was constructed using serially diluted pooled cDNAs for each primer set used in qPCR in each run. The standard curve was used to determine the PCR efficiency and reproducibility of each PCR system. The Hmbs gene was used as reference gene normalisation according to the method as described .
Two or three independent biological replicates were used for each tissue/organ in each experiment. Two qPCR experiments were performed on the tissue of each biological replicate. The qPCR results were normalized to Hmbs, and those that were not outliers, log2 transformed and then averaged to give the expression data for the biological replicate. One-way ANOVA was used to compare the expression levels among the tissues. A P value of <0.05 was considered statistically significant. Where significant differences were detected among the tissues the least significant difference(s) (LSD) were provided with the analysis (see Additional file 14 for analysis details).
Paraffin embedded sections (8 μm) were used for LNA-ISH. Sections were de-paraffinised with washes in xylene (3× for 5 minutes each) and hydrated in a series of ethanol concentrations into RNase-free water. Subsequently, sections were fixed in 4% (w/v) PFA (pH7.0) in 1X PBS (10 minutes) followed by Proteinase K digestion (6.7 μg/ml of Proteinase K, 50 mM of Tris HCl pH7.5, 5 mM of EDTA) for 30 minutes, re-fixed in 4% (w/v) PFA in 1X PBS for 5 minutes and acetylated (0.1 M of triethanolamine, 0.178% (v/v) of concentrated HCl and 0.25% (v/v) of acetic anhydride) for 10 minutes. Between each step, sections were washed multiple times using 1X PBS.
The pre-hybridisation step was carried out in a humidified chamber (50% (v/v) formamide, 5X sodium chloride/sodium citrate, SSC) at 60°C. Amersham Rapid-hyb™ Buffer (GE Healthcare) was used for pre-hybridisation with additional Escherichia coli tRNA (Sigma Aldrich) and Herring Sperm DNA (Promega) to a final concentration of 100 μg/ml each. After 1-2 hours of pre-hybridisation, custom-made Sox4_sir3 LNA probes (Cat. no: EQ-70537, Exiqon) were added to the buffer to give a concentration of 0.020 pmol/μl. Hybridisation was carried out in the oven for 16-20 hours.
After the hybridisation step, sections were washed in 5 × SSC (20 minutes at hybridisation temperature) followed by 0.2 × SSC (3 hours at hybridisation temperature). Sections were then rinsed in fresh 0.2 × SSC for 5 minutes and in pre-blocking buffer (0.1 M of Tris HCl pH7.5, 0.15 M of NaCl and 240 μg/ml of levamisole) for a further 5 minutes. In a humidified chamber, sections were blocked in 20% (v/v) foetal calf serum (Sigma Aldrich) and 2% (w/v) blocking powder (Roche Diagnostics) in maleate buffer for 1 hour. After blocking, sections were incubated with 0.0002X (0.00015 U) anti-DIG antibody with alkaline phosphatase, Fab fragments (Roche Diagnostics) in blocking buffer for 16 hours in the dark. Subsequently, sections were washed in NTMT buffer (3× for 10 minutes each: 0.1 M Tris HCl pH9.5, 0.1 M NaCl, 0.05 M MgCl2, 1% (v/v) Tween-20 and 240 μg/ml levamisole) and then with nitro blue tetrazolium chloride (NBT)/5-Bromo-4-chloro-3-indolyl phosphate, toluidine salt (BCIP) colour reaction (0.375 mg/ml of NBT and 0.188 mg/ml of BCIP in NTMT buffer) for 3 hours to 5 days. After the colour reaction step, sections were washed with Tris EDTA buffer pH8.0 (0.01 M of Tris HCl pH7.5 and 0.001 M EDTA pH8.0) for 10 minutes and were mounted in Entellan® media (ProSciTech).
Mouse embryonic stem (mES) cells with Dicer1 activity were of a line heterozygous for a conditionally mutant Dicer1 allele (Dicer1c) and a null Dicer1 allele (Dicer1-), these genetic modifications have been previously described . mES cells without Dicer1 activity were produced by transient transfection of this Dicer1c/- line with Cre recombinase to produce Dicer1-/- subclones (JRM and DMM, unpublished data). The mES cells were propagated as previously described .
C57BL/6 females of 3-4 weeks of age were superovulated using 5IU of Folligon (PMSG) followed by 5IU of Chorulon (HCG) 47.5 hours later and mated with B6D2F1 entire stud males. Microdrop culture dishes were set up to equilibrate in 37°C, 5% CO2 incubator 4 hours prior to culture. KSOM (Millipore) media was used in 20 μl droplets in a 35 mm dish, overlaid with Embryo Tested Mineral Oil (Sigma). Superovulated female mice were sacrificed after 2.5 days of superovulation induction and mating, and oviducts were collected into M2 handling media (Millipore). Oviducts were flushed using M2 media, a blunt 30G needle and a1ml syringe. Morulae were collected and cultured in pre-equilibrated KSOM. Blastocysts were collected from culture a day later under a dissecting microscope. These were considered E3.5 blastocysts.
KHL, JRR, JMR and DLA participated in the small RNA sequence analysis and annotations. KHL, PJB and CNH supervised, designed and carried out the qPCR analysis. KHL and TD performed the small RNA northern analysis. PQT supervised whereas KHL and PSC performed the LNA-ISH analysis. SP performed the procedures for superovulation and mating of mice, cultured the morulae and provided the blastocysts for the expression analysis. DMM and JRM cultured and provided the mES cells with Dicer1 conditional allele. KHL drafted the manuscript. CNH, PQT, DLA and HSS conceived of the study, and participated in its design and coordination. All authors read and approved the final manuscript.
List of 413,494 unique tags.
List of unique tags mapped to repetitive elements and ncRNAs based on the 3' end sequences.
List of unique tags mapped to repetitive elements and ncRNAs based on the 5' end sequences.
List of unique tags mapped to miRNAs, pre-miRNAs or miRNA-star based on 3' end sequences.
List of unique tags mapped to RefSeq sequences based on 3' end sequences.
List of unique tags mapped to RefSeq sequences based on 5' end sequences.
List of unique tags mapped to redundant mouse ESTs based on 3' end sequences.
List of unique tags mapped to redundant mouse ESTs based on 5' end sequences.
List of unique tags mapped to a single locus in the mouse genome based on 3' end sequences.
List of unique tags mapped to a single locus in the mouse genome based on 5' end sequences.
List of unique tags mapped to multiple loci in the mouse genome based on 3' end sequences.
List of unique tags mapped to multiple loci in the mouse genome based on 5' end sequences.
List of known miRNAs in the E15.5 developing mouse brain.
Supplementary figures and data for statistical analysis.
This work was supported by National Health and Medical Research Council fellowships (171601 and 461204 to H.S.S); National Health and Medical Research Council Grants 219176, 257501 and 257529 (to H.S.S.) and a fellowship from Pfizer Australia (to P.Q.T.). K.-H.L. was a recipient of the Melbourne International Fee Remission Scholarship (MIFRS) and Universiti Putra Malaysia Staff Training Scholarship (UPMSTS), and an Adelaide Fees Scholarship International equivalent. We thank GeneWorks Pty Ltd for constructing the small RNA (cDNA) library and performing the high-throughput sequencing.